Market Overview:
The global vaccine for influenza market is expected to grow at a CAGR of 9.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of influenza, increasing awareness about the benefits of vaccination, and technological advancements in the field of vaccine development. The trivalent influenza vaccine segment is expected to dominate the global market during the forecast period owing to its high demand and widespread use. However, the quadrivalent influenza vaccine segment is projected to grow at a higher CAGR from 2018 to 2030 due its advantages over trivalent vaccines such as broader protection against different strains of flu virus and increased patient convenience. On basis of application, children (6 months-3 years) are expected account for majority share in terms revenue generated by global vaccine for influenza market during forecast period followed by adults and children over 3 years age group segments respectively. This can be attributed growing awareness among parents regarding importance vaccinations for their children coupled with government initiatives towards immunization programs across various countries worldwide .Regionally, North America is anticipated hold dominant position in terms revenue generated by global Vaccine For Influenza Market throughout forecast period followed by Europe region .
Product Definition:
A vaccine is a preparation of killed or weakened viruses, bacteria, or other organisms used to prevent disease. A vaccine for influenza is a shot that helps protect you from getting the flu. It is important to get vaccinated each year because different types of flu viruses circulate each season.
Trivalent Influenza Vaccine:
Trivalent influenza vaccine is a type of vaccine that protects against three strains of the flu; there are two types of vaccines available in the market, one is trivalent and other is quadrivalent. Trivalent influenza vaccines protect against both Type A and B viruses. Quadrivalent influenza vaccine only protects against Type A virus. The choice between these depends on an individuals risk factors for different viruses, such as asthma or diabetes.
Quadrivalent Influenza Vaccine:
The quadrivalent influenza vaccine is a type of influenza vaccine that protects against four different strains of the flu. It is approved for use in people over 65 years of age and individuals with chronic diseases or medical conditions, such as asthma, diabetes, cardiovascular disease, renal disease or cancer.
Quadrivalent vaccines are preferred by healthcare providers because they offer better protection against several viruses compared to trivalent vaccines.
Application Insights:
Based on the application, the global vaccine for influenza market is segmented into children (6 months to 3 years), adults and children above 3 years. The use of vaccines in children 6 months to 3 years of age is considered routine immunization against a disease. This procedure does not require any specific indications or recommendations as it has been proven beneficial for both child and adult population, provided they are healthy enough to withstand the effects of an infection.
The vaccination among adults has become a popular trend as it offers certain advantages over other preventive measures such as injections or tablets that have to be taken every day. Moreover, growing awareness about immunization among people above 60 years globally along with advancements in technology used for manufacturing vaccines will boost growth during forecast period.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturers and research institutes involved in developing new vaccines is one of the major factors contributing to its dominance. In addition, increasing demand for flu vaccine from private as well as public sectors is expected to propel growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising awareness about vaccination programs among people and increasing government initiatives for immunization activities coupled with rising healthcare expenditure by countries such as China & Japan are some other factors driving regional market growth.
The European region accounted for more than 20% share in 2017 owing to increase investment by governments towards R&D on influenza vaccines along with rise adoption rates across several countries especially Italy, Spain.
Growth Factors:
- Increasing incidence of influenza and other respiratory infections across the globe
- Growing awareness about the benefits of vaccination against influenza
- Rising demand for preventive healthcare measures among people
- Technological advancements in vaccine development and manufacturing processes
- increasing funding for research on new vaccine technologies
Scope Of The Report
Report Attributes
Report Details
Report Title
Vaccine for Influenza Market Research Report
By Type
Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine
By Application
For Children (6 months to 3 years), For Adults and Children over 3 years
By Companies
Sanofi, CSL, GSK, Mylan, Hulan Bio, AstraZeneca, CCBIO
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
160
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Vaccine for Influenza Market Report Segments:
The global Vaccine for Influenza market is segmented on the basis of:
Types
Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
For Children (6 months to 3 years), For Adults and Children over 3 years
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- CSL
- GSK
- Mylan
- Hulan Bio
- AstraZeneca
- CCBIO
Highlights of The Vaccine for Influenza Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Trivalent Influenza Vaccine
- Quadrivalent Influenza Vaccine
- By Application:
- For Children (6 months to 3 years)
- For Adults and Children over 3 years
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vaccine for Influenza Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A vaccine is a medicine or other agent that helps the body build immunity to a particular disease. The influenza (flu) vaccine helps protect against the flu, which can be very serious and even deadly.
Some of the key players operating in the vaccine for influenza market are Sanofi, CSL, GSK, Mylan, Hulan Bio, AstraZeneca, CCBIO.
The vaccine for influenza market is expected to register a CAGR of 9.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Vaccine for Influenza Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Vaccine for Influenza Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Vaccine for Influenza Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Vaccine for Influenza Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Vaccine for Influenza Market Size & Forecast, 2020-2028
4.5.1 Vaccine for Influenza Market Size and Y-o-Y Growth
4.5.2 Vaccine for Influenza Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Trivalent Influenza Vaccine
5.2.2 Quadrivalent Influenza Vaccine
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 For Children (6 months to 3 years)
6.2.2 For Adults and Children over 3 years
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Vaccine for Influenza Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Vaccine for Influenza Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Trivalent Influenza Vaccine
9.6.2 Quadrivalent Influenza Vaccine
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 For Children (6 months to 3 years)
9.10.2 For Adults and Children over 3 years
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Trivalent Influenza Vaccine
10.6.2 Quadrivalent Influenza Vaccine
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 For Children (6 months to 3 years)
10.10.2 For Adults and Children over 3 years
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Trivalent Influenza Vaccine
11.6.2 Quadrivalent Influenza Vaccine
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 For Children (6 months to 3 years)
11.10.2 For Adults and Children over 3 years
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Trivalent Influenza Vaccine
12.6.2 Quadrivalent Influenza Vaccine
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 For Children (6 months to 3 years)
12.10.2 For Adults and Children over 3 years
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Trivalent Influenza Vaccine
13.6.2 Quadrivalent Influenza Vaccine
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 For Children (6 months to 3 years)
13.10.2 For Adults and Children over 3 years
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Vaccine for Influenza Market: Competitive Dashboard
14.2 Global Vaccine for Influenza Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 CSL
14.3.3 GSK
14.3.4 Mylan
14.3.5 Hulan Bio
14.3.6 AstraZeneca
14.3.7 CCBIO
